Eagle Pharma gets tentative FDA approval for Lilly's Alimta version

(Reuters) - Eagle Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration tentatively approved its diluted version of Eli Lilly and Co's blockbuster cancer drug Alimta.The drug, Pemfexy, aims to treat patients with advanced stage of non-small cell lung cancer and mesothelioma, a rare type of tumor often caused by asbestos..The company expects to capture about 25 percent or a third of the market, Chief Executive Scott Tarriff said in an interview.A final approval - which would al